Literature DB >> 27720005

Epidemiology of Brain Tumors.

Katharine A McNeill1.   

Abstract

Brain tumors are the commonest solid tumor in children, leading to significant cancer-related mortality. Several hereditary syndromes associated with brain tumors are nonfamilial. Ionizing radiation is a well-recognized risk factor for brain tumors. Several industrial exposures have been evaluated for a causal association with brain tumor formation but the results are inconclusive. A casual association between the common mutagens of tobacco, alcohol, or dietary factors has not yet been established. There is no clear evidence that the incidence of brain tumors has changed over time. This article presents the descriptive epidemiology of the commonest brain tumors of children and adults.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Glioma; Ionizing radiation; Medulloblastoma; Meningioma; Neurofibromatosis; Pituitary adenoma

Mesh:

Year:  2016        PMID: 27720005     DOI: 10.1016/j.ncl.2016.06.014

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  92 in total

Review 1.  Vaccination in the immunotherapy of glioblastoma.

Authors:  Ziren Kong; Yu Wang; Wenbin Ma
Journal:  Hum Vaccin Immunother       Date:  2017-12-11       Impact factor: 3.452

2.  BRCA1-associated protein inhibits glioma cell proliferation and migration and glioma stem cell self-renewal via the TGF-β/PI3K/AKT/mTOR signalling pathway.

Authors:  Bo Wang; Chen Cao; Xi Liu; Xin He; Hao Zhuang; Dong Wang; Budong Chen
Journal:  Cell Oncol (Dordr)       Date:  2019-11-27       Impact factor: 6.730

Review 3.  Applications of high-resolution magic angle spinning MRS in biomedical studies II-Human diseases.

Authors:  Christopher Dietz; Felix Ehret; Francesco Palmas; Lindsey A Vandergrift; Yanni Jiang; Vanessa Schmitt; Vera Dufner; Piet Habbel; Johannes Nowak; Leo L Cheng
Journal:  NMR Biomed       Date:  2017-09-15       Impact factor: 4.044

Review 4.  From imaging to biology of glioblastoma: new clinical oncology perspectives to the problem of local recurrence.

Authors:  A Zygogianni; M Protopapa; A Kougioumtzopoulou; F Simopoulou; S Nikoloudi; V Kouloulias
Journal:  Clin Transl Oncol       Date:  2018-01-15       Impact factor: 3.405

5.  MicroRNA-548c-3p inhibits T98G glioma cell proliferation and migration by downregulating c-Myb.

Authors:  Jianyi Lu; Min Zhang; Xiao Yang; Tong Cui; Jinpo Dai
Journal:  Oncol Lett       Date:  2017-03-17       Impact factor: 2.967

Review 6.  A Practical Approach to the Differential Diagnosis of Intracranial Tumors: Gross, Histology, and Immunoprofile-based Algorithm.

Authors:  George S Stoyanov; Lilyana Petkova; Deyan L Dzhenkov
Journal:  Cureus       Date:  2019-12-15

Review 7.  Leptin Involvement in Primary Brain and Pituitary Tumors: Therapeutic Potential, Prognostic Value, and Proposed Diagnostic Application.

Authors:  Christos Bikis; Theodora Tzanavari; Krystallenia I Alexandraki; Stamatios Theocharis
Journal:  Horm Cancer       Date:  2018-02-20       Impact factor: 3.869

8.  Amino-Functionalized Mesoporous Silica Nanoparticle-Encapsulated Octahedral Organoruthenium Complex as an Efficient Platform for Combatting Cancer.

Authors:  Marina Martínez-Carmona; Quy P Ho; Jérémy Morand; Ana García; Enrique Ortega; Luiza C S Erthal; Eduardo Ruiz-Hernandez; M Dolores Santana; José Ruiz; Maria Vallet-Regí; Yurii K Gun'ko
Journal:  Inorg Chem       Date:  2020-07-06       Impact factor: 5.165

9.  Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors.

Authors:  Anthony R Guastella; Sharon K Michelhaugh; Neil V Klinger; Hassan A Fadel; Sam Kiousis; Rouba Ali-Fehmi; William J Kupsky; Csaba Juhász; Sandeep Mittal
Journal:  J Neurooncol       Date:  2018-04-17       Impact factor: 4.130

Review 10.  Clinical Presentation and Management of Headache in Pituitary Tumors.

Authors:  Himanshu Suri; Carrie Dougherty
Journal:  Curr Pain Headache Rep       Date:  2018-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.